Airtonomy, Inc. specializes in the development of innovative aerial imagery solutions and aircraft detection systems. Founded in 2018 and headquartered in Grand Forks, North Dakota, the company aims to enhance the safety of air travel by manufacturing aircraft detection lighting systems that activate red lights on wind turbines, making them visible to nearby aircraft. In addition to this, Airtonomy is focused on creating a comprehensive framework for secure, remote, autonomous multi-drone operations. Their approach integrates technical, methodological, and policy aspects to provide a holistic solution that offers significant time, cost, and accuracy benefits compared to traditional specialist contractors.
Neurogenesis
Series A in 2022
Neurogenesis develops a proprietary approach for sustained delivery of remyelinating proteins using patients' own stem cells. This technology, NG CELL™, involves collecting bone marrow from the patient.
OWL Autonomous Imaging
Series A in 2022
Owl Autonomous Imaging, Inc. is a technology company founded in 2018 and headquartered in Fairport, New York. The company specializes in developing advanced imaging solutions, including a two-color infrared camera designed for the US Air Force and a cutting-edge 4D camera that integrates 1550nm Flash-LiDAR with thermal imaging. These innovations target the automotive mobility and industrial markets, offering Monocular 3D Thermal Ranging™ capabilities that enhance safety in various conditions by leveraging deep learning techniques to produce dense range maps from heat signatures without the need for external illumination. Co-founded by Chuck Gershman, who has extensive experience in the semiconductor industry and a track record of successful entrepreneurial ventures, Owl Autonomous Imaging aims to revolutionize how sensing technology is applied in autonomous vehicles and other sectors.
SunDensity
Venture Round in 2021
SunDensity Inc. is a Boston-based company that specializes in the research, design, and development of innovative Photonic Smart Coating (PSC™) technology. Established in 2016, the company focuses on enhancing efficiencies in photonics through the up and down conversion of light wavelengths, addressing various inefficiencies in the field. SunDensity's PSC™ technology is designed to lower electricity costs generated by solar photovoltaic applications, optimize the thermal and optical properties of architectural glass, and improve the quantum efficiency of optoelectronic instruments. The company also maintains an office in Rochester, New York, where it continues to advance its groundbreaking technologies.
Conamix
Venture Round in 2021
Founded in 2014, Conamix specializes in developing and commercializing advanced materials for the global lithium-ion battery market. Its innovative, low-cost, high-energy materials are designed to enhance energy density while reducing costs, seamlessly integrating into existing manufacturing infrastructure.
RealEats is a food technology company specializing in premium meal prep delivery services that focus on providing healthy, convenient meals while minimizing food waste. The company offers a range of chef-designed meals made from whole, unprocessed ingredients, including vegetables, grains, meats, and fish. These meals are prepared using responsibly sourced components, with a significant portion obtained from local farms in the Finger Lakes region of New York State, where RealEats operates its kitchen. Delivered directly to consumers in single portion sizes, the meals are vacuum-packed to ensure freshness and convenience, allowing customers to easily access nutritious and handmade food options.
Karma Wellness Water
Seed Round in 2020
Karma Wellness Water is a manufacturer of naturally enhanced flavored spring water, designed to provide a nutritious beverage option. The company offers water that contains high levels of vitamins and nutrients, delivered in a mix-to-drink format through its innovative push cap bottles. This packaging allows consumers to access a proprietary blend of probiotics, vitamins, and antioxidants at their optimal potency, promoting both health and convenience.
Casana, officially known as Heart Health Intelligence Inc., is a healthcare technology company based in Rochester, New York, founded in 2018. It specializes in developing innovative solutions for heart health monitoring, primarily through its flagship product, the Heart Seat. This smart toilet seat is designed to facilitate effortless and continuous in-home health monitoring by capturing essential clinical measurements such as heart rate, blood pressure, cardiac output, ECG, and blood oxygenation. The Heart Seat integrates advanced sensors, including a single-lead ECG, embedded photoplethysmogram LEDs, and sensitive weight sensors, to monitor cardiac activity. By offering a cloud-connected platform, Casana enables healthcare practitioners to track patients' cardiac health beyond traditional clinical settings, thereby enhancing the management of chronic conditions and improving patient outcomes through reliable and consistent vital signs analysis.
WexEnergy
Pre Seed Round in 2020
WexEnergy LLC, established in 2018 and headquartered in Rochester, New York, specializes in manufacturing plastics and developing innovative window insulation technology. The company aims to enhance the energy efficiency of aging windows by providing an affordable solution that improves comfort and reduces energy bills. WexEnergy's transparent window insulation system is designed to upgrade single-pane windows to perform like efficient double-pane windows, optimizing thermal insulation properties and benefiting customers with a proper thermal barrier. This technology helps building owners increase cash flow, leading to higher property values and more profitable businesses by making existing windows work more efficiently.
VPG Medical
Seed Round in 2020
VPG Medical Inc. is a digital health service company based in Rochester, New York, established in 2017. The company specializes in developing innovative monitoring solutions that utilize video-based sensors embedded in smart devices and personal computers. Its flagship product, CardioGuard, provides cardiac monitoring technology aimed at diagnosing and treating various health conditions, including congestive heart failure, diabetes, atrial fibrillation, hypertension, sleep apnea, obesity, and stroke. By enabling continuous health status monitoring during daily activities, VPG Medical enhances the ability for patients to stay informed about their cardiac health, ultimately contributing to improved diagnoses and therapeutic strategies.
Adarza BioSystems
Series D in 2020
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.
Soos Technology
Venture Round in 2020
Soos Technology develops an incubation system designed to influence the sex development of poultry embryos. The system uses AI-driven software to monitor and control incubation conditions within a customized incubation cell and applies sound waves to the embryos, enabling genetic male chicks to become functional female layers capable of laying eggs. By enabling sex conversion during incubation, the technology aims to increase egg production capacity for the poultry industry and support global nutritional security.
EkoStinger
Venture Round in 2019
EkoStinger specializes in advanced trailer aerodynamics solutions for the trucking industry. Its signature product, the Sliding Stinger, actively adjusts with tandem axles to ensure optimal fuel efficiency across all driving conditions.
Rialto Markets
Seed Round in 2019
Rialto Markets is a New York City-based platform founded in 2016 that combines crowdfunding and advisory services to connect investors with early-stage companies. The firm specializes in equity crowdfunding and institutional investment, assisting with Regulation Crowdfunding, Regulation A, and Regulation D capital raises, and provides a platform for investors to access opportunities in emerging ventures.
Kinvolved
Seed Round in 2018
Kinvolved, Inc. is a technology company that develops mobile and web applications aimed at enhancing communication between schools and families, with a particular focus on improving student attendance and reducing chronic absenteeism. Its flagship product, KiNVO, allows for streamlined messaging to parents and guardians regarding attendance, behavior, grades, and school updates. The platform also provides tools for tracking attendance trends, identifying chronically absent students, and facilitating targeted interventions. Kinvolved's solutions cater to a diverse audience, including district leaders, school principals, teachers, and after-school program leaders, particularly in underserved communities across the United States. Founded in 2012 and headquartered in New York City, Kinvolved combines technology with expert consulting and community engagement to foster better educational outcomes and enhance family involvement in the academic process.
Splyce
Venture Round in 2018
Splyce, established in 2015 and based in Rochester, New York, operates an online platform that serves as a comprehensive guide to eSports events across North America and Europe. It connects fans with crucial event information and facilitates communication between attendees and organizers. Additionally, Splyce hosts a prominent editorial hub featuring insights from industry leaders and fields professional eSports teams in popular games such as CS:GO, Hearthstone, and League of Legends.
Glauconix Biosciences
Seed Round in 2018
Glauconix Biosciences, Inc. is a biotechnology company based in Albany, New York, that focuses on reducing the cost of ophthalmic drug development through innovative platform technology. Established in 2014, the company specializes in pharmaceutical research and offers a range of services, including drug screening, dose response analysis, biological and physiological assessments, as well as safety and toxicity evaluations. Glauconix develops advanced ex-vivo dynamic 3D human tissue models that closely mimic actual human physiology and integrate human genetics, facilitating rapid testing and discovery across diverse population genetics. This approach allows for the identification and validation of effective compounds and biologics, enhancing the drug development process for ophthalmic applications.
WexEnergy
Seed Round in 2018
WexEnergy LLC, established in 2018 and headquartered in Rochester, New York, specializes in manufacturing plastics and developing innovative window insulation technology. The company aims to enhance the energy efficiency of aging windows by providing an affordable solution that improves comfort and reduces energy bills. WexEnergy's transparent window insulation system is designed to upgrade single-pane windows to perform like efficient double-pane windows, optimizing thermal insulation properties and benefiting customers with a proper thermal barrier. This technology helps building owners increase cash flow, leading to higher property values and more profitable businesses by making existing windows work more efficiently.
EkoStinger
Seed Round in 2018
EkoStinger specializes in advanced trailer aerodynamics solutions for the trucking industry. Its signature product, the Sliding Stinger, actively adjusts with tandem axles to ensure optimal fuel efficiency across all driving conditions.
GRYT Health
Seed Round in 2018
GRYT Health is a digital health company focused on improving health outcomes for individuals facing cancer and other chronic illnesses. Utilizing proprietary direct-to-patient technology, GRYT Health offers valuable patient data, research analytics, and clinical trial recruitment services to pharmaceutical companies throughout the drug development and commercialization process. The company’s unique access to patient insights has established it as a preferred partner for many leading pharmaceutical and biotech companies, as well as clinical research organizations. By facilitating patient education and marketing services, GRYT Health empowers individuals to take charge of their health, ultimately aiming to enhance the overall patient experience and outcomes in the healthcare landscape.
CypherWorx
Venture Round in 2017
CypherWorx, Inc., operating as CollaborNation, is a provider of eLearning courses and training services tailored for professionals in the public, nonprofit, and small business sectors. Founded in 2007 and headquartered in Rochester, New York, the company offers a comprehensive learning management system that allows users to browse interactive courses, curate digital libraries, and facilitate discussions through message posts. CollaborNation enables administrators to customize the platform with their organization's branding and specific training needs, while also providing tools for tracking learner progress, managing training events, and generating reports. The platform is utilized across various industries, including K-12 education, social services, child care, and emergency services, supporting clients in their efforts to develop skills and meet performance goals.
Tencar, Inc. is a company that specializes in developing ostomy appliances designed specifically for active-lifestyle colostomy and ileostomy patients. Incorporated in 2011 and based in Batavia, New York, Tencar offers the Choice Cap System, which features a double-flanged attachment method. This system includes a lightweight, airtight, and molded waterproof cap that can be used with or without a traditional soft inner pouch. The Choice Cap System consists of three main components: the Choice Cap, a plastic prosthetic device for managing fecal waste; the Dual-Flanged Choice Cap Wafer, which serves multiple purposes; and a pouch that attaches to the wafer's inner flange for added protection and security. By providing a reliable barrier against leakage and odors, Tencar's products enhance the confidence and quality of life for the nearly one million ostomy patients in the United States.
Sanabit Technologies
Seed Round in 2017
Sanabit Technologies specializes in the development of non-invasive medical technology aimed at enhancing wound and bone healing. The company utilizes low-intensity magnetic fields to stimulate the body's natural repair processes, thereby improving the efficiency of cellular functions, particularly in mitochondria. This innovative approach leads to quicker recovery times, enhanced healing, and healthier tissue, all while being low-cost, pain-free, and non-intrusive. Sanabit Technologies focuses on providing effective solutions that empower patients to harness their body's innate healing capabilities.
Diligence Lab
Seed Round in 2017
Diligence Lab is a company that specializes in developing innovative solutions for genetic diagnostics and human genetic screening, offering cost-effective test kits. Additionally, it provides a talent management platform that leverages artificial intelligence and machine learning to help enterprises, individuals, and government agencies address unconscious bias in hiring. By analyzing data from global databases, social media, and the Dark Web, the platform assists students in finding job opportunities that align with their skills and interests while enabling employers to identify pre-assessed candidates who match their organizational culture.
SelfArray
Seed Round in 2017
SelfArray, founded in 2015 and based in Troy, New York, specializes in directed self-assembly technology that streamlines the assembly of chip-on-board (CoB) LED displays into pixel arrays. By utilizing diamagnetic levitation, SelfArray's innovative approach allows for the rapid and cost-effective assembly of millions of LEDs, facilitating their transfer to final printed circuit boards for bonding in parallel. This technology not only reduces costs for direct-view LED display manufacturers but also supports the industry's transition to more economical, unpackaged LED solutions.
Viggi Kids
Venture Round in 2017
Viggi Kids, Corp. is a Fairport, New York-based company that specializes in designing and manufacturing innovative seating solutions for children. Its flagship product, the Vidget chair, is a versatile three-in-one model that can easily transform from a chair to a desk or stool, catering to various learning and play environments. Additionally, the company offers the Digit Widgit, an educational tool that aids children in learning mathematical concepts. The Vidget chair features a flexible seating system that allows for side-to-side and front-to-back rocking motion, which helps children manage energy and enhances focus and attention. Suitable for classrooms, daycare centers, and home settings, Viggi Kids emphasizes the importance of an adaptable and engaging environment for children's development. Founded in 2015, the company also sells its products online, targeting both educational institutions and individual consumers.
Conamix
Seed Round in 2016
Founded in 2014, Conamix specializes in developing and commercializing advanced materials for the global lithium-ion battery market. Its innovative, low-cost, high-energy materials are designed to enhance energy density while reducing costs, seamlessly integrating into existing manufacturing infrastructure.
Traverse Biosciences
Seed Round in 2016
Traverse Biosciences, Inc. is a bioscience company founded in 2013 and located in Stony Brook, New York. The company specializes in commercializing innovative drug candidates aimed at treating inflammatory diseases and age-related conditions in both humans and companion animals. Its lead product, TRB-N0224, is a once-daily prescription medication designed to prevent and control canine periodontal disease by addressing inflammation through the modulation of matrix metalloproteinases and pro-inflammatory mediators. In addition to TRB-N0224, Traverse is exploring complementary therapeutic applications for this drug and developing further candidates that have implications for veterinary and human medicine. The company's mission focuses on bridging the gap between early-stage academic research and viable commercial products, ultimately improving health outcomes and contributing to societal welfare.
Sensor Films
Venture Round in 2016
Sensor Films Inc. is at the forefront of advancing digital manufacturing processes with significant applications across various industries. The company has developed the Starlight Digital Manufacturing Platform, which utilizes inkjet deposition technology to facilitate rapid and cost-effective prototyping and high-volume production. This platform serves the specialty graphics and printable electronics sectors, enabling manufacturers to streamline their workflows and enhance efficiency. By providing additive manufacturing solutions, Sensor Films offers integrated systems that allow for the printing of functional and decorative inks on both flexible and rigid substrates. This capability supports the production of electronic product assemblies for a diverse range of consumer and industrial applications, ultimately reducing time to market and enabling economical short-run production.
Construction Robotics
Venture Round in 2016
Founded in 2007, Construction Robotics designs, develops, and manufactures semi-automated masonry systems. Its focus is on advancing construction through technology, aiming to improve productivity, efficiency, and worker quality of life.
GiveGab
Seed Round in 2015
GiveGab is a company that specializes in online fundraising services tailored for nonprofit organizations, community foundations, and educational institutions. Founded in 2011 and headquartered in Ithaca, New York, the company offers a comprehensive suite of products designed to facilitate fundraising efforts. Its platform connects nonprofits with volunteers and donors, promoting community giving through donations and peer-to-peer fundraising. By enabling organizations to effectively promote their programs and events, GiveGab fosters relationships among fundraisers, volunteers, and the communities they serve.
Pharmapotheca A
Seed Round in 2015
Pharmapotheca A is a pharmaceutical company focused on the development and commercialization of drugs and technologies for the treatment of attention deficit hyperactivity disorder in children and adults. Founded in 2014 and based in Delmar, New York, the company develops novel pharmaceutical technologies and chemistries using analytical method design to solve organic synthesis challenges, with the aim of expanding treatment options for ADHD. In addition to its ADHD programs, Pharmapotheca A provides technology development and consulting services to the pharmaceutical, veterinary, cosmetic, agrochemical, nutritional, and flavor and fragrance industries.
Molecular Glasses
Seed Round in 2015
Founded in 2015 and headquartered in Rochester, New York, Molecular Glasses specializes in the development of non-crystallized molecular glasses for stable and long-lived organic electronics. The company focuses on creating a range of products including hole-transporting, electron-transporting, ambipolar, fluorescent, phosphorescent, cross-linkable, and soluble materials to enhance OLED technology.
Efferent Labs
Seed Round in 2014
Efferent Labs is a biotechnology company specializing in implantable biosensors for life sciences. Its flagship product, CytoComm, enables wireless monitoring of biological signaling and cellular responses, benefiting researchers and clinicians alike. Applications include preclinical research, clinical testing, oncology, cardiology, and metabolic diseases.
First Wave Technologies
Venture Round in 2014
First Wave Technologies, Inc. is a technology firm based in Batavia, New York, focused on advancing medical devices, pharmaceuticals, diagnostics, and consumer market sectors. The company supports researchers and organizations in bringing their technologies to market by providing a complete management team to facilitate the development and introduction of innovative ideas. First Wave's medical devices aim to enhance the effectiveness and precision of pharmaceutical delivery, thereby improving the healthcare experience for patients and caregivers. By leveraging clinical insights and engineering expertise, First Wave Technologies strives to establish new standards of care in the healthcare industry.
Augmate
Seed Round in 2014
Augmate Corporation is an enterprise-focused company that specializes in developing a platform for industrial smart eyewear applications tailored for deskless workers. Founded in 2013 and based in New York, the company offers an IoT and wearable device management platform that enables organizations to create and deploy cloud-based applications for smart eyewear across various industries, including agriculture, automotive, aviation, construction, manufacturing, medical, and pharmaceuticals. Through its InnoVision program, Augmate allows businesses to evaluate and pilot wearable technology in workplace settings, while its secure, blockchain-based platform manages the integration and connectivity of multiple wearable devices. The platform also optimizes information distribution, ensuring a safe and productive work environment, and supports partnerships with leading hardware manufacturers such as Google Glass and Vuzix.
Yorango
Seed Round in 2014
Yorango is a company focused on simplifying the rental process through the development of a comprehensive real estate platform. It offers property-management software that assists clients, particularly landlords, in negotiating favorable terms for leases and sub-rentals. In addition to its core software offerings, Yorango provides a range of real estate consultancy services, including general practice surveying and destination consulting. The company aims to help clients acquire the right properties at competitive prices, enhancing the overall efficiency and effectiveness of property management.
MICROrganic Technologies
Seed Round in 2013
MICROrganic Technologies is a biotechnology company that develops and commercializes microbial fuel cell platforms for industrial and municipal wastewater treatment. Its modular bio-electrochemical systems cut energy consumption by reducing or eliminating aeration, while converting organic waste energy into electricity and delivering real-time process data. The technology supports secondary treatment with digital tools and routine tests for organic waste and microbes, enabling high energy efficiency. The company was established in 2010 and is based in Castleton-On-Hudson, New York.
StrongArm Tech
Seed Round in 2013
StrongArm Technologies, Inc. is a safety science company that specializes in developing data collection and assessment solutions aimed at enhancing the safety of industrial workers. The company offers a risk monitoring device that utilizes machine learning to analyze risks related to musculoskeletal injuries, along with the FUSE Risk Management Platform, a cloud-based IoT-enabled software that leverages motion-interpreting sensors for real-time monitoring and assessment. Additionally, StrongArm provides a posture feedback system designed to assist industrial workers with proper lifting mechanics and postural support. Founded in 2011 and headquartered in Brooklyn, New York, StrongArm Technologies focuses on improving workplace safety through innovative technology.
GiveGab
Seed Round in 2013
GiveGab is a company that specializes in online fundraising services tailored for nonprofit organizations, community foundations, and educational institutions. Founded in 2011 and headquartered in Ithaca, New York, the company offers a comprehensive suite of products designed to facilitate fundraising efforts. Its platform connects nonprofits with volunteers and donors, promoting community giving through donations and peer-to-peer fundraising. By enabling organizations to effectively promote their programs and events, GiveGab fosters relationships among fundraisers, volunteers, and the communities they serve.
VitaScan
Seed Round in 2013
VitaScan is a medical device company specializing in the development of finger-stick tests for vitamin and micronutrient deficiencies. Its initial focus is on iron deficiency, which affects approximately one-third of the global population but often goes undetected by standard methods.
GiveGab
Seed Round in 2013
GiveGab is a company that specializes in online fundraising services tailored for nonprofit organizations, community foundations, and educational institutions. Founded in 2011 and headquartered in Ithaca, New York, the company offers a comprehensive suite of products designed to facilitate fundraising efforts. Its platform connects nonprofits with volunteers and donors, promoting community giving through donations and peer-to-peer fundraising. By enabling organizations to effectively promote their programs and events, GiveGab fosters relationships among fundraisers, volunteers, and the communities they serve.
Yorango
Seed Round in 2012
Yorango is a company focused on simplifying the rental process through the development of a comprehensive real estate platform. It offers property-management software that assists clients, particularly landlords, in negotiating favorable terms for leases and sub-rentals. In addition to its core software offerings, Yorango provides a range of real estate consultancy services, including general practice surveying and destination consulting. The company aims to help clients acquire the right properties at competitive prices, enhancing the overall efficiency and effectiveness of property management.
Graphenix Development
Seed Round in 2012
Graphenix Development.(“GDI”), founded in 2009, is a leader in graphenic dispersions, coatings, and high value applications. GDI's core competitive advantage is product oriented chemistry. GDI produces "Graphenic Intermediate Dispersion Systems" under their product line GRIDS(TM). GDI has developed a conductive ink with IIMAK, that was launched globally in Q1 2013. GDi will continue to develop new products with current and new partners.
Pharmadva
Seed Round in 2011
PharmAdva develops a product that delivers improved quality of life for patients.
e2e Materials
Series A in 2010
e2e Materials, Inc. is a biocomposite manufacturer based in Ithaca, New York, established in 2006. The company specializes in designing, developing, and producing innovative biocomposites for the furniture, cabinetry, and other related markets. Its products are derived from sustainable materials, specifically soy flour and natural fibers such as jute, flax, and kenaf, which not only enhance strength but also offer biodegradability. e2e Materials aims to transform the industrial wood products marketplace by providing a more environmentally friendly alternative to traditional wood composites, significantly outperforming legacy products in performance and sustainability. The company serves a global customer base through distribution partners, focusing on enabling manufacturers to reduce operational costs and improve efficiency while adhering to stringent environmental regulations. By fostering a regional business model, e2e Materials contributes to job creation across agriculture, manufacturing, and technology sectors, promoting a greener economy.
AndroBioSys
Venture Round in 2009
AndroBioSys, Inc. (ABS), is a biotechnology company dedicated to the development of novel treatments for prostate disease. Based on technologies developed at Roswell Park Cancer Institute, AndroBioSys is pioneering new approaches to make treatment of prostate cancer curative, not palliative. Preventing progression of prostate disease is intertwined intimately with disruption of the androgen axis. ABS performs contract research screening services for academic, biotechnology and pharmaceutical clients and develops collaborative partnerships to discover new drugs to proprietary prostate disease targets.
Koning develops computed tomography technology for breast imaging, delivering 3D breast CT that produces high-contrast real 3D images with high spatial resolution in about 10 seconds and with radiation levels similar to diagnostic mammography, eliminating painful compression. The technology aims to improve early detection, diagnosis, and treatment of breast cancer by enabling clearer visualization of breast tissue, potentially improving patient survival and outcomes. Plans call for future versions to extend benefits to other body areas and offer a lower-cost imaging option that could substitute several traditional imaging methods.
Cerion Technology
Series A in 2007
Cerion Technology produces diesel and power products.
TetraGenetics
Seed Round in 2007
TetraGenetics, Inc. is a biotechnology company focused on developing therapeutic proteins and vaccines for the biopharmaceutical industry. Established in 2004 and based in Arlington, Massachusetts, the company employs its proprietary TetraExpress system to produce recombinant human ion channel proteins, which are essential for creating complex therapeutic agents. Among its offerings is IchVax, a recombinant subunit vaccine aimed at preventing white-spot disease in freshwater fish. TetraGenetics specializes in producing difficult-to-express eukaryotic membrane and secretory proteins, including vaccine antigens and monoclonal antibodies, which are crucial for treating various human and animal diseases. The company is also engaged in a strategic research and development collaboration with Imbrium Therapeutics L.P., further enhancing its capabilities in therapeutic innovation.
TetraGenetics
Seed Round in 2005
TetraGenetics, Inc. is a biotechnology company focused on developing therapeutic proteins and vaccines for the biopharmaceutical industry. Established in 2004 and based in Arlington, Massachusetts, the company employs its proprietary TetraExpress system to produce recombinant human ion channel proteins, which are essential for creating complex therapeutic agents. Among its offerings is IchVax, a recombinant subunit vaccine aimed at preventing white-spot disease in freshwater fish. TetraGenetics specializes in producing difficult-to-express eukaryotic membrane and secretory proteins, including vaccine antigens and monoclonal antibodies, which are crucial for treating various human and animal diseases. The company is also engaged in a strategic research and development collaboration with Imbrium Therapeutics L.P., further enhancing its capabilities in therapeutic innovation.